Dose Cancer Research Results
Dose, Dosage: Click to Expand ⟱
| Source: |
| Type: |
Drug dosage vs efficacy, and actual dosage number of research papers.
|
Nor, Normal Healthy: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
| - |
in-vitro, |
BC, |
MCF-7 |
|
|
|
- |
in-vitro, |
Nor, |
MCF10 |
|
|
|
- |
in-vitro, |
BC, |
MDA-MB-231 |
|
|
|
- |
in-vitro, |
BC, |
BT549 |
|
|
|
- |
in-vivo, |
BC, |
MDA-MB-231 |
|
|
|
ROS↑, DNAdam↑, selectivity↑, TumCG↓, RadioS↑, Dose↝, selectivity↑, other↝, eff↓, eff↑, γH2AX↑, Dose↓, eff↑,
| - |
in-vitro, |
BC, |
MDA-MB-231 |
|
|
|
- |
in-vitro, |
BC, |
T47D |
|
|
|
- |
in-vitro, |
Nor, |
MCF10 |
|
|
|
TumCD↑, DNAdam↑, *antiOx↑, *AntiTum↑, Inflam↓, tumCV↓, Bcl-2↓, Apoptosis↓, selectivity↑, eff↑, Dose↓,
Inflam↓, IL6↓, MCP1↓, COX2↓, PGE2↓, MMP2↓, MMP9↓, DNAdam↑, eff↝, Telomerase↓, Bcl-2↓, AMPK↑, ROS↑, MMP↓, ATP↓, p‑mTORC1↓, p‑S6K↓, ERK↓, PI3K↓, PTEN↑, Akt↓, Raf↓, MEK↓, Dose↓, Dose↑, selectivity↑, TumCCA↑, eff↑, EGFR↓, Glycolysis↓, Dose?, p27↑, CDK2↓, CDK4↓, cycD1/CCND1↓, cycE/CCNE↓, Bax:Bcl2↑, Casp3↑, Casp9↑, VEGFR2↓, ChemoSen↑, eff↑, eff↑, PGE2↓, JAK2↓, STAT3↓, CXCR4↓, CCR7↓, uPA↓, CSCs↓, EMT↓, Diff↓, CD133↓, Nestin↓, n-MYC↓, NOTCH↓, SOX2↓, Hif1a↓, VEGF↓, RadioS↑,
*MusCon↓, *Dose↓, *eff↑, *Temp↝,
*neuroP↑, *GSH↑, *HO-1↑, *NADPH↑, *Trx1↑, *TrxR1↑, *NRF2↑, *ROS↓, *antiOx↑, *BBB↑, Dose↓,
*AMPK↑, *P21↑, *Dose↓, *chemoPv↑,
Showing Research Papers: 1 to 6 of 6
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 6
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
ROS↑, 2,
Mitochondria & Bioenergetics ⓘ
ATP↓, 1, MEK↓, 1, MMP↓, 1, Raf↓, 1,
Core Metabolism/Glycolysis ⓘ
AMPK↑, 1, Glycolysis↓, 1, p‑S6K↓, 1,
Cell Death ⓘ
Akt↓, 1, Apoptosis↓, 1, Bax:Bcl2↑, 1, Bcl-2↓, 2, Casp3↑, 1, Casp9↑, 1, p27↑, 1, Telomerase↓, 1, TumCD↑, 1,
Transcription & Epigenetics ⓘ
other↝, 1, tumCV↓, 1,
DNA Damage & Repair ⓘ
DNAdam↑, 3, γH2AX↑, 1,
Cell Cycle & Senescence ⓘ
CDK2↓, 1, CDK4↓, 1, cycD1/CCND1↓, 1, cycE/CCNE↓, 1, TumCCA↑, 1,
Proliferation, Differentiation & Cell State ⓘ
CD133↓, 1, CSCs↓, 1, Diff↓, 1, EMT↓, 1, ERK↓, 1, p‑mTORC1↓, 1, n-MYC↓, 1, Nestin↓, 1, NOTCH↓, 1, PI3K↓, 1, PTEN↑, 1, SOX2↓, 1, STAT3↓, 1, TumCG↓, 1,
Migration ⓘ
MMP2↓, 1, MMP9↓, 1, uPA↓, 1,
Angiogenesis & Vasculature ⓘ
EGFR↓, 1, Hif1a↓, 1, VEGF↓, 1, VEGFR2↓, 1,
Immune & Inflammatory Signaling ⓘ
CCR7↓, 1, COX2↓, 1, CXCR4↓, 1, IL6↓, 1, Inflam↓, 2, JAK2↓, 1, MCP1↓, 1, PGE2↓, 2,
Drug Metabolism & Resistance ⓘ
ChemoSen↑, 1, Dose?, 1, Dose↓, 4, Dose↑, 1, Dose↝, 1, eff↓, 1, eff↑, 6, eff↝, 1, RadioS↑, 2, selectivity↑, 4,
Clinical Biomarkers ⓘ
EGFR↓, 1, IL6↓, 1,
Total Targets: 67
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress ⓘ
antiOx↑, 2, GSH↑, 1, HO-1↑, 1, NRF2↑, 1, ROS↓, 1, Trx1↑, 1, TrxR1↑, 1,
Core Metabolism/Glycolysis ⓘ
AMPK↑, 1, NADPH↑, 1,
Cell Cycle & Senescence ⓘ
P21↑, 1,
Barriers & Transport ⓘ
BBB↑, 1,
Cellular Microenvironment ⓘ
Temp↝, 1,
Drug Metabolism & Resistance ⓘ
Dose↓, 2, eff↑, 1,
Functional Outcomes ⓘ
AntiTum↑, 1, chemoPv↑, 1, MusCon↓, 1, neuroP↑, 1,
Total Targets: 18
Scientific Paper Hit Count for: Dose, Dosage
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:49 Cells:% prod#:% Target#:1114 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page